Physiological role of nitric oxide in regulation of renal function in humans

American Journal of Physiology - Renal Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Haynes, William G ^a,d   Hand, Malcolm F ^a,e   Dockrell, Mark E C ^a   Eadington, David W ^a,f   Lee, Michael R ^a   Hussein, Ziad ^b   Benjamin, Nigel ^c   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^f HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dopamine; Endothelins; Endothelium derived relaxing factor; Kidney; Platelet

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTERY TONE; ARTICLE; BLOOD PRESSURE REGULATION; DOPAMINERGIC SYSTEM; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; KIDNEY INNERVATION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION; VASCULAR RESISTANCE;

EID: 0030771418     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.272.3.f364     Document Type: Article

References (31)

1. Born, G. V. R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929, 1962.
2. Castillo, L., T. C. deRojas, T. E. Chapman, J. Vogt, J. F. Burke, S. R. Tannenbaum, and V. R. Young. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc. Natl. Acad. Sci. USA 90: 193-197, 1993.
3. De Nicola, L., R. C. Blantz, and F. B. Gabbai. Nitric oxide and angiotensin II: glomerular and tubular interaction in the rat. J. Clin. Invest. 89: 1248-1256, 1992.
4. Deng, X., W. J. Welch, and C. S. Wilcox. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int. 46: 639-646, 1994.
5. Eadington, D. W., S. Freestone, C. J. Waugh, C. P. Swainson, and M. R. Lee. Lithium pretreatment affects renal and systemic responses to angiotensin II infusion in normal man. Clin. Sci. (Colch.) 82: 543-549, 1992.
6. 15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138, 1982.
7. Hansen, J., T. N. Jacobsen, and R. G. Victor. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans. Hypertension 24: 439-444, 1994.
8. Haynes, W. G., M. F. Hand, H. A. Johnstone, P. L. Padfield, and D. J. Webb. Direct and sympathetically mediated venoconstriction in essential hypertension: enhanced responses to endothelin-1. J. Clin. Invest. 94: 1359-1364, 1994.
9. Haynes, W. G., J. P. Noon, B. R. Walker, and D. J. Webb. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertens. 11: 1375-1380, 1993.
10. Imig, J. D., and R. J. Roman. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 19: 770-774, 1992.
11. Kohno, M., K. Murakawa, K. Yasunari, K. Yokokawa, T. Horio, N. Kurihara, and T. Takeda. Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats. Metabolism 38: 712-713, 1989.
12. Koomans, H. A., W. H. Boer, and E. J. Dorhout-Mees. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int. 36: 2-12, 1989.
13. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1033-F1037, 1991.
14. Lee, M. R. Dopamine and the kidney: ten years on. Clin. Sci. (Colch.) 84: 357-375, 1993.
15. MacDonald, T. M., R. F. Jeffrey, S. Freestone, and M. R. Lee. (+)-Sulpiride antagonises the renal effects of γ-L-glutamyl-L-dopain man. Br. J. Clin. Pharmacol. 25: 203-212, 1988.
16. Mattson, D. L., R. J. Roman, and A. W. Cowley, Jr. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 19: 766-769, 1992.
17. McKee, M., C. Scavone, and J. A. Nathanson. Nitric oxide, cGMP, and hormonal regulation of active sodium transport. Proc. Natl. Acad. Sci. USA 91: 12056-12060, 1994.
18. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
19. Nakamura, T., A. M. Alberola, and J. P. Granger. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide. Hypertension 21: 956-960, 1993.
20. Perrella, M. A., F. L. Hildebrand, Jr., K. B. Marguiles, and J. C. Burnett, Jr. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R323-R328, 1991.
21. Persson, P. B., J. E. Baumann, H. Ehmke, E. Hackenthal, H. R. Kirchhein, and B. Nafz. Endothelium-derived NO stimulates pressure-dependent renin release in conscious dogs. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F943-F947, 1993.
22. Schultz, P. J., A. E. Schorer, and L. Raij. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F162-F167, 1990.
23. Signon, D. H., O. A. Carretero, and W. H. Beierwaltes. Endothelium-derived relaxing factor regulates renin release in vivo. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F256-F261, 1992.
24. Soares-da-Silva, P., M. Pestana, M. A. Vieira-Coelho, M. H. Fernandas, and A. Albino-Teixeira. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br. J. Pharmacol. 114: 1403-1413, 1995.
25. Stamler, J. S., E. Loh, M. A. Roddy, K. E. Currie, and M. A. Creager. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035-2040, 1994.
26. Thomas, S. H. L. Impedance cardiography using the Sramek-Bernstein method: accuracy, and reproducibility at rest and during exercise. Br. J. Clin. Pharmacol. 34: 467-476, 1992.
27. G-nitro-L-arginine in conscious sheep. J. Cardiovasc. Pharmacol. 24: 144-150, 1994.
28. Vallance, P., N. Benjamin, and J. Collier. The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man. Eur. J. Clin. Pharmacol. 42: 37-41, 1992.
29. Vallance, P., A. Leone, A. Calver, J. Collier, and S. Moncada. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1: 572-575, 1992.
30. Wennmalm, A., G. Benthin, A. Edlund, L. Jungersten, N. Kieler-Jensen, S. Lundin, U. Nathorst-Westfelt, A.-S. Petersson, and F. Waagstein. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ. Res. 73: 1121-1127, 1993.
31. Wiinberg, N., S. Walter-Larson, C. Eriksen, and P. E. Nielsen. An evaluation of semi-automatic blood pressure manometers against intra-arterial blood pressure. J. Ambulatory Monitoring 1: 303-309, 1988.